Yueyun Chen

458 total citations
27 papers, 301 citations indexed

About

Yueyun Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yueyun Chen has authored 27 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Yueyun Chen's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Yueyun Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Yueyun Chen collaborates with scholars based in China, Ireland and South Korea. Yueyun Chen's co-authors include Peipei Wang, Chun Wang, Zhenyu Ding, Qing Li, Ting Liu, Yang Fu, Yong Wu, Yue Zheng, Deguo Wang and Yong Wu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Yueyun Chen

25 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yueyun Chen China 9 170 108 71 64 62 27 301
Yiming Zhao China 10 131 0.8× 72 0.7× 122 1.7× 62 1.0× 39 0.6× 19 293
Yibo Cai China 10 169 1.0× 55 0.5× 76 1.1× 61 1.0× 29 0.5× 19 295
Yawei Qian China 9 167 1.0× 68 0.6× 139 2.0× 96 1.5× 95 1.5× 17 361
Xiaobo Bo China 11 124 0.7× 99 0.9× 88 1.2× 138 2.2× 52 0.8× 24 278
Yuji Hirami Japan 10 222 1.3× 162 1.5× 96 1.4× 32 0.5× 145 2.3× 21 405
Andrea Lanese Italy 9 259 1.5× 127 1.2× 58 0.8× 74 1.2× 44 0.7× 28 371
Paul Mésange France 6 68 0.4× 89 0.8× 91 1.3× 28 0.4× 32 0.5× 12 224
Yuqiu Xu China 9 126 0.7× 123 1.1× 123 1.7× 24 0.4× 59 1.0× 18 288
Ankit Patel United States 11 85 0.5× 79 0.7× 99 1.4× 15 0.2× 51 0.8× 26 285
Xinping Cao China 9 149 0.9× 85 0.8× 94 1.3× 110 1.7× 29 0.5× 15 353

Countries citing papers authored by Yueyun Chen

Since Specialization
Citations

This map shows the geographic impact of Yueyun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueyun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueyun Chen more than expected).

Fields of papers citing papers by Yueyun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueyun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueyun Chen. The network helps show where Yueyun Chen may publish in the future.

Co-authorship network of co-authors of Yueyun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yueyun Chen. A scholar is included among the top collaborators of Yueyun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueyun Chen. Yueyun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Zhen, Zikuan Chen, Lijiao Pei, Yueyun Chen, & Zhenyu Ding. (2025). Prospects and Challenges of Lung Cancer Vaccines. Vaccines. 13(8). 836–836. 1 indexed citations
2.
Chen, Yueyun, et al.. (2025). Different survival and recurrence patterns between neoadjuvant radiochemotherapy and immunochemotherapy in esophageal squamous cell carcinoma. Current Problems in Surgery. 64. 101722–101722. 1 indexed citations
3.
Chen, Yueyun, Peipei Wang, Yang Hu, et al.. (2024). Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial. British Journal of Cancer. 131(7). 1126–1136. 6 indexed citations
4.
Chen, Yueyun, et al.. (2024). The rupture risk of intracranial saccular aneurysm: a case—control study based on a three-dimensional computed tomography angiography model. Quantitative Imaging in Medicine and Surgery. 14(5). 3339–3349.
5.
Chen, Yueyun, Zhenyu Ding, Yong Yuan, et al.. (2024). Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. 42(3_suppl). 352–352.
6.
Zheng, Yue, et al.. (2023). Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion. Current Oncology. 30(11). 9929–9939. 3 indexed citations
7.
8.
Li, Qing, Ye Hong, Yang Fu, et al.. (2022). Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer. Scientific Reports. 12(1). 22372–22372. 15 indexed citations
9.
10.
Fu, Yang, Yue Zheng, Peipei Wang, Yueyun Chen, & Zhenyu Ding. (2022). Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient. Frontiers in Pharmacology. 13. 817265–817265. 7 indexed citations
11.
Zhou, Yuwen, Qingfang Li, Yueyun Chen, et al.. (2022). Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study. European Journal of Surgical Oncology. 48(7). 1559–1566. 11 indexed citations
12.
Liu, Ying, Yu‐Ping Zhou, Mai Zhang, et al.. (2021). Clinicopathologic Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer. Journal of Oncology. 2021. 1–9. 5 indexed citations
13.
Li, Qing, Zhen Lin, Peipei Wang, et al.. (2021). Viral infections and the efficacy of PD-(L)1 inhibitors in virus-related cancers: Head and neck squamous cell carcinoma and hepatocellular carcinoma. International Immunopharmacology. 100. 108128–108128. 18 indexed citations
14.
Zhou, Yuwen, Ruolan Xia, Yueyun Chen, Xuelei Ma, & Jiyan Liu. (2021). Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database. European Journal of Surgical Oncology. 47(8). 2108–2118. 8 indexed citations
15.
Chen, Yueyun, Peipei Wang, Yang Fu, et al.. (2021). Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors. Journal of bone oncology. 29. 100369–100369. 5 indexed citations
16.
Wang, Peipei, Yueyun Chen, & Chun Wang. (2021). Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy. Frontiers in Oncology. 11. 672677–672677. 84 indexed citations
17.
Fu, Yang, Yue Zheng, Peipei Wang, Yueyun Chen, & Zhenyu Ding. (2021). Pulmonary Lymphoepithelioma-Like Carcinoma Treated with Immunotherapy or Chemotherapy: A Single Institute Experience. OncoTargets and Therapy. Volume 14. 1073–1081. 10 indexed citations
18.
Fu, Yang, Yuan Tang, Yue Zheng, et al.. (2020). <p>Imaging Pattern of Diffuse Intrapulmonary Metastases in Lung Cancer Was Associated with Poor Prognosis to Epidermal Growth Factor Receptor Inhibitors</p>. Cancer Management and Research. Volume 12. 11761–11772. 1 indexed citations
19.
Chen, Yueyun, Ye Hong, Yang Fu, et al.. (2019). Sequential Administration of EGFR-TKI and Pemetrexed Achieved a Long Duration of Response in Advanced NSCLC Patients with EGFR-mutant Tumours. Asian Pacific Journal of Cancer Prevention. 20(8). 2415–2420. 1 indexed citations
20.
Wang, Deguo, Yong Wu, Yueyun Chen, et al.. (2018). Focal selective chemo-ablation of spinal cardiac afferent nerve by resiniferatoxin protects the heart from pressure overload-induced hypertrophy. Biomedicine & Pharmacotherapy. 109. 377–385. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiming Zhao Breakdown of academic impact, for papers by Yibo Cai Breakdown of academic impact, for papers by Yawei Qian Breakdown of academic impact, for papers by Xiaobo Bo Breakdown of academic impact, for papers by Yuji Hirami Breakdown of academic impact, for papers by Andrea Lanese Breakdown of academic impact, for papers by Paul Mésange Breakdown of academic impact, for papers by Yuqiu Xu Breakdown of academic impact, for papers by Ankit Patel Breakdown of academic impact, for papers by Xinping Cao
Rankless by CCL
2026